Allied Market Research
Upcoming Allied Market Research
Pet Cancer Therapeutics Market

Pet Cancer Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

Pages: NA
Dec 2021 | 368 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pet Cancer Therapeutics Market

Request Now !

Pet Cancer Therapeutics Market Outlook - 2027

Cancer in pets can be of many forms such as soft tissue sarcomas and mast cell tumors, which potentially can be cured or restricted from spreading further with the help of long-term treatment. Pet cancer therapeutics refer to the novel anti-cancer drugs used while treating cancer capable of suppressing the effect of cancerous cells and restricting their growth. In cases, where incurable forms of cancer emerge, the aim of veterinary professionals is to prolong survival while maintaining or improving pet’s quality of life and reducing the pain. It is a common disease in pets especially dogs and cats. Pet cancer covers a wide range of specific diagnostics against various forms of cancer. Cancer treatment in pets often involves a combination of care involving a veterinarian and cancer care professional. Pet cancer therapeutics varies depending upon the type of cancer and its stage, may be the use of just one therapy or include combination of therapies including tumor removal surgery, chemo therapy, radiation therapy, TomoTherapy, immune therapy and others. The current studies related to pet oncology disciple emphasize on improving efficacy and reduction of side effects of novel anticancer drugs.

Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Product, Animal species, cancer type and Region

  Regions covered

•             North America (U.S., Canada, Mexico)

•             Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•             Asia-Pacific (Japan, China, India, Australia, South Korea, Rest          of Asia-Pacific)

•             LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

Elanco ,AB Science, Aratana Therapeutics, ELIAS Animal Health, Karyopharms Therapeutics, Merial Inc., Regeneus, VetiVax, VetDC Inc. and Zoetis.

COVID – 19 scenario analysis: 

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • In addition, it has been observed after some research that people with prevalence of cardiac diseases are at higher risk for mortality and morbidity related to COVID-19 compared to the average population
  • Due to diversion of medical field towards treating COVID-19,the funding to R&D activities related to pet oncology has been reduced, manufacture of ventilators essential for COVID-19 treatment has been prioritized and as a result, this segment have to face negligence subsequently causing negative impact on pet cancer therapeutics market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Major factors driving the growth for pet cancer therapeutics market include the increasing prevalence of cancers in cats and dogs, heavy investments in research and development activities associated with oncology treatment and management in pets. The Veterinary Cancer Society stated that cancer resulted fatalities on 47% of dogs and was the leading cause of death in dogs, especially dogs with age over 10 years, and 32% of cats, in 2017. The most common form of cancers found in cats are leukemia and lymphoma. There has been a correlation between the prevalence of cancer and rising age of cancer, however it was also observed that some breeds showed higher cancer rates than other breeds. Additionally, growing consciousness regarding pet healthcare and treatments available in the market coupled with rise in existence of the high number of marketed drugs and vaccines for cancer treatment are further expected to propel the market. Industry players in the market with extensive product pipelines and innovative product launches will further lead to pet cancer therapeutics market development.

On the contrary, adverse effects due to cancer therapeutics for the treatment of oncology conditions in pets and the ignorance of pet owners to put their pets on medications are the restrains hampering the growth of pet cancer therapeutics market. Dearth of veterinary oncologists, low expenditure on pet healthcare in developing and under-developed economies and lack of awareness about pet diseases and treatment among the pet owners will impede the growth of market.

Recent technological advancements to drive the market

Owing to current research and studies in animal oncology and treatment has resulted into various technological developments in the recent times. The major emphasis is laid on the development of anticancer drugs and improvising their efficacy and reducing potential adverse effects of the drugs on the body of pets. Till 2015, various research organizations and related projects concentrated on genetic mechanisms in canine cells for development of highly target specific and efficient therapies for animal cancer treatment. Moreover, Animal Cancer Foundation, Petco Foundation, PetCure Oncology, Veterinary Cancer Society and other organizations are working collectively for development of targeted anti-cancer therapeutics and treatments with minimal adverse backlashes in terms of harmful aftereffects.

Furthermore, sanctioning of research grants in the field of animal oncology for the development of breakthrough anti-cancer therapies with reduced side effects are increasing. For example, the Animal Cancer Foundation (ACF) received a research grant of $1 million in 2015, from the Blue Buffalo Foundation. This research grant was primarily to support and accelerate cancer treatment research that prioritized at conducting research and exploratory studies to investigate the similarities between cancers in humans and pets to find efficient therapeutics in both the cases.

North America to dominate the market

North American region is set to dominate the pet cancer therapeutics throughout pertaining to rising pet adoption, increasing per capita expenditure on animal healthcare, rise in the occurrence of pet cancers, and presence of robust healthcare infrastructure facility as well as leading market players in the region. Around 90 million dogs are pets owned in the U.S., according to statistics of the American Pet Products Association (APPA). Additionally, the stats published by APPA, stated the expenditure on pet healthcare is estimated to be $75.38 billion by 2019. Further, prominent awareness regarding pet diseases and healthcare management among the pet owners will exponentially surge the growth of pet cancer therapeutics market in the region.

Key segments:




  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • TomoTherapy
  • Other Therapies

  Animal Species

  • Cats
  • Dogs
  • Other Pets

  Cancer Types

  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer


  • North America
  • Europe
  • Asia-Pacific

Key benefits of the report:

  • This study presents the analytical depiction of the global pet cancer therapeutics stem industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global pet cancer therapeutics market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global pet cancer therapeutics market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global pet cancer therapeutics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Pet cancer therapeutics Market research report:

  • What are the leading market players active in the pet cancer therapeutics market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Pet Cancer Therapeutics Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers